Version 2.77

Description

Bivalirudin (trade names Angiomax or Angiox) is a specific and reversible direct thrombin inhibitor (DTI). It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life. Clinical studies demonstrated bivalirudin can be used to treat patients with stable angina, unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) undergoing PCI. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Bivalirudin (Wikipedia)

Basic Part Properties

Part Display Name
Bivalirudin
Part Type
Component (Describes the core component or analyte measured)
Created On
2012-12-19
Construct for LOINC Short Name
Bivalirudin

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP171388-4
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP171388-4

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 比伐卢定
Synonyms: 比伐芦定;比伐芦丁;抗凝药
es-ES Spanish (Spain) Bivalirudina
it-IT Italian (Italy) Bivalirudina
tr-TR Turkish (Turkey) Bivalirudin
ru-RU Russian (Russian Federation) Бивалирудин
nl-NL Dutch (Netherlands) bivalirudine